A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases	autoimmune disease, immune system disorder	Recruiting	Early phase 1	2026-03-24		NCT06747156

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Abogen Life Sciences (Shanghai) Co., Ltd.	3
Ruijin Hospital	454

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Nanjing Drum Tower Hospital	Nanjing	China	22
Ruijin Hospital	Shanghai	China	21
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	77

Clinical trials